AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialization of primary care and specialty care medicines.
Phone: +44 20 7604 8000
2 Kingdom Street
London, W2 6BD
England, United Kingdom
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-02-08 | Rani Therapeutics | Series E | $53M | Bossa Nova Investimentos, Cathay Venture, GeneScience Pharmaceuticals, Google Ventures, Novartis, Ping An Ventures, Shire, and Virtus Ventures |
| 2017-11-29 | PhaseBio Pharmaceuticals | Convertible Note - II | $8.1M | Fletcher Spaght Ventures, Hatteras Venture Partners, Johnson & Johnson Innovation, New Enterprise Associates, and Syno Capital |
| 2017-11-27 | Dizal Pharma | Corporate Minority | State Development & Investment Corporation | |
| 2017-10-23 | ADC Therapeutics | Private Equity - V | $200M | Auven Therapeutics, Redmile Group, and Wild Family Office |
| 2017-09-10 | Rani Therapeutics | Series D | $39M | Bossa Nova Investimentos, Cathay Ventures, Crystal Horizon Investments, Google Ventures, Novartis, Pacific Venture Opportunity Fund, Pinemount Investments, and PurpleSky Capital |
